MetaCap

electroCore Inc. (ECOR)

NASDAQ: ECORHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD

4.42-0.43 (-8.87%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ECOR stock chart

Technical analysis

Key statistics

All statistics
Market cap
$40.78M
EPS (TTM)
-$1.36
52-week range
3.90 – 12.70
Day range
3.90 – 4.97
Volume / Avg
631.55K / 120.32K
Beta
—

52-week range

$3.90$12.70

ECOR stock today

On Nov 20, ECOR ended the session at $4.42, shedding $0.43 (8.87%), versus the S&P 500's 3.70% decline. Volume was 5.2x the average at 631.55K shares, a sign of unusually heavy trading. Shares are 65.2% below their 52-week high of $12.70, set on Sep 22, 2026 and 13.3% above the 52-week low of $3.90, near the bottom of the past year's range.

ECOR is down 1.4% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 6.2%. electroCore has posted a net loss over the last twelve months (EPS of -$1.36), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About electroCore

Company profile

electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga 350, a personal use consumer electronics general wellness product and Truvaga Plus, an app-enabled general wellness product.

Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
CEO
Mr. Joshua S. Lev
Headquarters
Rockaway, NJ
Employees
83
IPO year
2018

Financial highlights

Full financials

In fiscal 2025, electroCore generated $32.0 million in revenue, up 27.2% from fiscal 2024, its 8th consecutive year of revenue growth. electroCore reported a net loss of $14.0 million, compared with a loss of $11.9 million a year earlier. Gross margin was 86.8% (up from 85.0%) and operating margin -41.1%.

electroCore annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$32.03M$25.18M$16.03M$8.59M$5.45M
Growth+27.20%+57.09%+86.57%+57.62%+55.93%
Net income$-13.97M$-11.89M$-18.83M$-22.16M$-17.22M
EPS (diluted)$-1.65$-1.59$-3.42$-4.69$-4.36

Analyst forecast

Forecast

Consensus (5 analysts)

none

Avg. price target

$19.17+333.71%

  • Strong buy 1
  • Buy 4
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $12.00High $26.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 4, 2026
EPS actual vs est.
$-0.13 vs $-0.26
Surprise
+50.00%

ECOR news

All ECOR news

electroCore peers

Health Care sector
ECOR peer companies
CompanyPrice% ChgMarket capCompare
POCIPrecision Optics Corporation Inc.4.12+1.41%$45.30Mvs ECOR
OMOutset Medical Inc.2.81-3.44%$53.03Mvs ECOR
QTIQT Imaging Holdings Inc.1.92+2.67%$28.21Mvs ECOR
HYPRHyperfine Inc. Class A0.5465+4.27%$57.96Mvs ECOR
NRXSNeuraxis Inc.4.22-6.22%$59.90Mvs ECOR
ITOCiTonic Holdings Ltd Class A1.59+6.00%$11.63Mvs ECOR
IRIXIRIDEX Corporation0.4449-4.59%$7.92Mvs ECOR
NDRAENDRA Life Sciences Inc.3.58-3.38%$5.36Mvs ECOR

Indexes, lists and sector

electroCore stock FAQ

What is electroCore's stock price today?

ECOR last traded at $4.42 as of Nov 20, 4:00 PM EST, down 8.87% on the day. Prices are delayed at least 15 minutes.

Does electroCore pay a dividend?

No. electroCore does not currently pay a regular cash dividend.

Who is electroCore's CEO?

Mr. Joshua S. Lev is the chief executive officer of electroCore Inc., which has about 83 employees.

Has ECOR ever split its stock?

Yes. The most recent ECOR stock split was a 1-for-15 split on Feb 15, 2023.

What is the ECOR 52-week high?

The 52-week high for ECOR is $12.70 and the 52-week low is $3.90. The stock is currently 65.2% below its high.

Compare ECOR